论文部分内容阅读
目的:探讨分析稳心颗粒合并比索洛尔治疗心肌病心律失常的临床影响及效果。方法:病例选取80例扩张型心肌病心律失常的患者,所有患者均在2012年2月至2013年2月在该院接受治疗,按入院时间将患者分为对照组和观察组两组,每组40例。两组患者使用不同的治疗方案,对照组:使用比索洛尔进行治疗;观察组:使用稳心颗粒合并比索洛尔进行治疗。对比治疗效果。结果:治疗效果方面根据数据可明显看出观察组患者优于对照组患者,总有效率95%。相比之下对照组总有效率只有85%,两组患者治疗有效率对比差异显著,具有统计意义(P<0.05)。而不良反应方面两组对比并无意义。结论:稳心颗粒合并比索洛尔治疗扩张型心肌病心律失常临床效果较好,安全性较高,有效提升患者的生活质量,减少患者的病死率,因此值得临床推广。
Objective: To investigate the clinical effect and effect of Wenxin granule combined with bisoprolol on cardiomyopathy arrhythmia. Methods: Eighty patients with arrhythmia of dilated cardiomyopathy were selected. All patients were treated in the hospital from February 2012 to February 2013. The patients were divided into control group and observation group according to the time of admission. Group of 40 cases. Two groups of patients with different treatment options, the control group: the use of bisoprolol treatment; observation group: the use of Wenxin particles combined with bisoprolol for treatment. Compare the treatment effect. Results: The treatment effect based on the data clearly shows that the observation group patients better than the control group patients, the total efficiency of 95%. In contrast, the control group, the total effective rate was only 85%, two groups of patients with significant difference in treatment efficiency, with statistical significance (P <0.05). The side effects of adverse reactions does not make sense. Conclusion: Wenxin granule combined with bisoprolol in the treatment of dilated cardiomyopathy arrhythmia clinical effect is better, higher safety, effectively improve the quality of life of patients and reduce the mortality of patients, it is worthy of clinical promotion.